Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALIVUS.NSthis companyAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
AARTIPHARM.NSAarti Pharmalabs Limited	₹921.40	32.96×	2.71×	3.16×	16.93×	-152.7%	54.1%	16.4%	9.6%	8.2%	7.3%	-3.2%	0.36×	1.94×	6.36×	1.49×	0.6%	6	4.24	3	B-
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
BALPHARMA.NSBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
COHANCE.NSCohance Lifesciences Limited	₹443.65	64.28×	2.95×	5.08×	27.48×	-9.7%	40.2%	10.6%	7.9%	4.6%	3.3%	1.2%	0.1×	0.79×	6.44×	2.78×	0.0%	6	9.25	3	B
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
Peer median	—	25.35×	2.71×	2.81×	13.13×	-9.7%	43.0%	10.9%	9.2%	8.2%	8.2%	0.8%	0.3×	1.11×	6.44×	1.76×	0.6%	5	6.74	2	—